Home
63. Chicken infectious anemia

Causative agent  
- CIA virus, family Circoviridae


Differential diagnosis  
- Infectious bursal disease
- Marek's disease
- Osteopetrosis virus infection
- Erythroblastosis virus infection
- Inclusion body hepatitis
- Vitamin K deficiency
- Intoxication with sulfonamide or mycotoxin



1. History taking  
- All ages of chickens are susceptible, the
  susceptibility rapidly decreases during the first 2-3
  weeks of life
- Vertical spread occurs following primary infection
  of in-lay breeders without showing any signs or
  other effects but results in clinical disease in their
  progeny towards the end of the second week of
  life
- Co-infection with other immunosuppressive agents
  increases the severity of the disease



2. Clinical examination  
- Anorexic depress
- Pallor of the comb and wattle
- Ruffled feathers and increasing daily mortality
- Peak mortality occurs within 5-6 days of onset of
  clinical signs and mortality has often declined to
  normal levels after a further 5-6 days
- Affected chickens often show focal skin lesions due
  to secondary infection leading to gangrenous
  dermatitis

3. Hematology  
- Anemia (hematocrit value ranging from 6-26%)


4. Necropsy  
- Thymus and bursa of Fabricius atrophy
- Pale, fatty bone marrow
- Ecchymotic skin hemorrhages on the wing, head,
  thighs and legs
- Discoloration, swelling of liver, kidney and spleen


5. Histopathological observation  
- Panmyelophthisis and generalized lymphoid
  atrophy in bone marrow
- Depletion of lymphocytes from the thymus, spleen,
  bursa of Fabricius and cecal tonsils followed by
  hyperplasia of reticular cells
- Swelling of hepatocytes and dilated sinusoids


6. Virus isolation  
Specimen : liver, spleen, feces ,circulating
lymphocytes  
Method    : MDCC-MSB1 cell culture inoculation
and CPE observation (cell death) 


7. Virus identification  
- IFA test
- SN test


Control  
- Monitoring of breeder flocks for the presence of
  immunity to CIA virus before laying
- Good sanitation and management to prevent
  immunosuppression
- Vaccination


149


-1- -2- -3- -4- -5- -6- -7-
@Copyright 2004